杜氏肌营养不良
肌营养不良蛋白
mdx鼠标
心肌细胞
线粒体
骨骼肌
生物
线粒体DNA
粒线体疾病
线粒体肌病
浪费的
内科学
内分泌学
肌营养不良
自噬
细胞生物学
医学
遗传学
细胞凋亡
基因
作者
Timothy M. Moore,Athena W. Lin,Alexander R. Strumwasser,Kevin Cory,Kate Whitney,Theodore Ho,Tammy Szu‐Yu Ho,Joseph L. Lee,Daniel H. Rucker,Christina Q. Nguyen,Aidan Yackly,Sushil K. Mahata,Jonathan Wanagat,Linsey Stiles,Lorraine P. Turcotte,Rachelle H. Crosbie,Zhenqi Zhou
标识
DOI:10.3389/fphys.2020.00690
摘要
Duchenne muscular dystrophy (DMD) is characterized by rapid wasting of skeletal muscle. Mitochondrial dysfunction is a well-known pathological feature of DMD. However, whether mitochondrial dysfunction occurs before muscle fiber damage in DMD pathology is not well known. Furthermore, the impact upon heterozygous female mdx carriers (mdx/+), who display dystrophin mosaicism, has received little attention. We hypothesized that dystrophin deletion leads to mitochondrial dysfunction, and that this may occur before myofiber necrosis. As a secondary complication to mitochondrial dysfunction, we also hypothesized metabolic abnormalities prior to the onset of muscle damage. In this study, we detected aberrant mitochondrial morphology, reduced cristae number, and large mitochondrial vacuoles from both male and female mdx mice prior to the onset of muscle damage. Furthermore, we systematically characterized mitochondria during disease progression starting before the onset of muscle damage, noting additional changes in mitochondrial DNA copy number and regulators of mitochondrial size. We further detected mild metabolic and mitochondrial impairments in female mdx carrier mice that were exacerbated with high-fat diet feeding. Lastly, inhibition of the strong autophagic program observed in adolescent mdx male mice via administration of the autophagy inhibitor leupeptin did not improve skeletal muscle pathology. These results are in line with previous data and suggest that before the onset of myofiber necrosis, mitochondrial and metabolic abnormalities are present within the mdx mouse.
科研通智能强力驱动
Strongly Powered by AbleSci AI